OKYO Pharma (OKYO) has been notified that the CEO Gary Jacob has purchased 10,000 of the Company’s ordinary shares on NASDAQ at a price of $1.04 per share. The company said, “We have also been notified that Panetta Partners Limited, an entity in which Gabriele Cerrone, the Executive Chairman, has a beneficial interest, purchased 20,000 of the Company’s ordinary shares on NASDAQ at a price of $1.04 per share. This brings the total shareholding of Cerrone to 9,871,570 shares which is 28.96% of issued share capital.”
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OKYO:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue